Aptose Biosciences Inc. (TSX:APS)
Canada flag Canada · Delayed Price · Currency is CAD
2.190
+0.030 (1.39%)
At close: Mar 6, 2026

Aptose Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.646.719.2536.9739.11117.39
Short-Term Investments
---9.9940.015
Cash & Short-Term Investments
1.646.719.2546.9679.13122.39
Cash Growth
-79.44%-27.51%-80.30%-40.65%-35.35%25.40%
Other Current Assets
2.142.822.642.562.612.68
Total Current Assets
3.789.5311.8949.5281.74125.08
Net Property, Plant & Equipment
0.290.61.11.510.791.19
Other Long-Term Assets
2.28-----
Total Assets
6.3410.1312.9951.0382.53126.26
Accounts Payable
1.461.266.056.331.72.17
Accrued Expenses
4.82.778.835.666.024.1
Current Portion of Leases
0.310.430.390.30.460.54
Other Current Liabilities
0.510.02----
Total Current Liabilities
7.084.4815.2712.288.176.81
Long-Term Debt
18.7110----
Long-Term Leases
-0.190.6210.120.54
Total Long-Term Liabilities
18.7110.190.6210.120.54
Total Liabilities
25.7914.6715.8913.298.297.35
Common Stock
459.77457.4444.81437.52437.39429.52
Additional Paid-in Capital
83.7783.3472.1568.8763.6750.86
Accumulated Other Comprehensive Income
-4.32-4.32-4.32-4.32-4.32-4.32
Retained Earnings
-558.68-540.97-515.54-464.33-422.51-357.15
Shareholders' Equity
-19.45-4.54-2.937.7474.24118.92
Total Liabilities & Equity
6.3410.1312.9951.0382.53126.26
Total Debt
19.0210.621.021.30.571.07
Net Cash (Debt)
-17.38-3.918.2445.6678.55121.32
Net Cash Growth
---81.96%-41.88%-35.25%26.28%
Net Cash Per Share
-8.26-5.6036.58222.68396.80667.10
Book Value
-19.45-4.54-2.937.7474.24118.92
Book Value Per Share
-9.24-6.50-12.88184.07374.99653.88
Tangible Book Value
-19.45-4.54-2.937.7474.24118.92
Tangible Book Value Per Share
-9.24-6.50-12.88184.07374.99653.88
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.